Bacterial colicin-immunity protein protein purification system
US-2024417426-A1 · Dec 19, 2024 · US
US9815871B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9815871-B2 |
| Application number | US-201414786304-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 23, 2014 |
| Priority date | Apr 23, 2013 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are methods and compositions relating to engineered curli fibers, e.g. CsgA polypeptide. In some embodiments, the methods and compositions described herein relate to functionalized biofilms.
Opening claim text (preview).
What is claimed herein is: 1. A functionalized engineered CsgA polypeptide comprising an activity polypeptide fused to a full-length Escherichia coli CsgA polypeptide by a flexible linker sequence; wherein the activity polypeptide comprises a conjugation domain; wherein the conjugation domain is specifically bound to a partner conjugation domain of a target polypeptide; wherein the target polypeptide comprises the partner conjugation domain fused to a functionalizing polypeptide; wherein the conjugation domain is selected from the group consisting of SpyTag, biotin acceptor peptide (BAP), biotin carboxyl carrier protein (BCCP), and a peptide comprising a LPXTG motif (SEQ ID NO: 23); wherein the partner conjugation domain is selected from the group consisting of SpyCatcher, streptavidin, and a peptide comprising aminoglycine; and wherein the flexible linker sequence comprises at least 6 amino acids. 2. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence consists of glycine and serine residues. 3. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 6 to 100 amino acids. 4. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 30 to 100 amino acids. 5. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 6 to 30 amino acids. 6. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 20 to 50 amino acids. 7. The functionalized engineered CsgA polypeptide of claim 1 , wherein the flexible linker sequence includes from 30 to 50 amino acids. 8. The functionalized engineered CsgA polypeptide of claim 1 , wherein the functionalizing polypeptide is an enzyme or an antibody. 9. The functionalized engineered CsgA polypeptide of claim 1 , wherein the conjugation domain or the functionalizing polypeptide further comprises an extracellular localization tag. 10. A biofilm including a functionalized engineered CsgA polypeptide comprising an activity polypeptide fused to a full length Escherichia coli CsgA polypeptide by a flexible linker sequence; wherein the activity polypeptide comprises a conjugation domain; wherein the conjugation domain is specifically bound to a partner conjugation domain of a target polypeptide; wherein the target polypeptide comprises the partner conjugation domain fused to a functionalizing polypeptide; wherein the conjugation domain is selected from the group consisting of SpyTag, biotin acceptor peptide (BAP), biotin carboxyl carrier protein (BCCP), and a peptide comprising a LPXTG motif (SEQ ID NO: 23); wherein the partner conjugation domain is selected from the group consisting of SpyCatcher, streptavidin, and a peptide comprising aminoglycine; and wherein the flexible linker sequence comprises at least 6 amino acids. 11. The functionalized engineered CsgA polypeptide of claim 1 , wherein the SpyTag comprises the amino acid sequence of SEQ ID NO: 9. 12. The biofilm of claim 10 , wherein the SpyTag comprises the amino acid sequence of SEQ ID NO: 9. 13. The biofilm of claim 10 , wherein the functionalizing polypeptide is an enzyme or an antibody. 14. A curli fiber comprising the functionalized engineered CsgA polypeptide of claim 1 . 15. A bacterial cell comprising the curli fiber of claim 14 .
Antibacterial agents · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
containing a domain for self-assembly, e.g. a viral coat protein (includes phage display) · CPC title
Escherichia (G) · CPC title
containing a tag with affinity for a non-protein ligand · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.